Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 12Brain Neoplasms 3Urogenital Diseases 2Neoplasms 2Disease 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Lobular 1

Interventions

Radiotherapy 3Carboplatin 3Trastuzumab 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2proto-oncogene protein c-fes-fps 1palbociclib 1gallium 68 PSMA-11 1fluciclovine F-18 1Vorinostat 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Radiation 1Paclitaxel 1Naltrexone 1Melphalan 1Letrozole 1Fulvestrant 1Fluorine-18 1Drugs, Generic 1Doxorubicin 1Docetaxel 1Crizotinib 1Counseling 1Chemotherapy, Adjuvant 1Albumin-Bound Paclitaxel 168Ga-DKFZ-PSMA-11 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Lobular × fluciclovine F-18 × Clear all
NCT04750473 2025-01-17

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Emory University

Phase 1 Completed
20 enrolled 7 charts

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡